1.The relationship between acute kidney injury and acute respiratory distress syndrome and pathogenesis
Chinese Pediatric Emergency Medicine 2021;28(4):337-340
Acute kidney injury and acute respiratory distress syndrome are the most common organ failure in intensive care unit with high mortality.Both lung and kidney are involved in maintaining acid-base balance in the body, and both organs contain a large vascular network, which is the primary target organ for distant organ effects in the failure of each other.This article reviewed the possible pathogenesis of lung-kidney cross-talk in renal injury or acute respiratory distress syndrome, in order to deepen the understanding of both diseases and improve the prognosis.
2.Transcatheter thrombolysis via the small saphenous vein for acute lower limb deep venous thrombosis
Xiaozhong HUANG ; Wei LIANG ; Jiwei ZHANG
Chinese Journal of General Surgery 2008;23(3):183-185
Objective To evaluate transcatheter thrombolysis via the small saphenous vein in the treatment for lower limb acute mix-deep venous thrombosis. Method From Jan 2005 to Mar 2007.37 patients with lower limb acute mix-DVT underwent catheter-directed thrombolysis via the small saphenous vein with urokinase(149 ±71)×104 IU continuous infusion.The venous patency score and the rate of patency improvement were observed by venograms before and after therapy.Twenty-two patients were followed up for(12 ±4)months. Results Venous patency score were significantly improved(Z=-5.330,P<0.01).The mean rate of venous patency was 50.17%±15%,and there was no complication.Venogram on 6~12 month follow up showed a venous patency of 58%±13%(Z=-3.545,P<0.01),and that on 13~18 months was 68%±20%(Z=-2.201,P<0.05). Conclusion This preliminary experience suggests that catheter-directed thrombolysis via the small saphenous vein with urokinase for acute lower limb mix-DVT iS safe and effective.
3.Treatment of lower extremty deep venous thrombosis in 165 patients
Xiaozhong HUANG ; Peng WANG ; Hao ZHANG
Chinese Journal of General Surgery 2000;0(11):-
Objective To evaluate the therapeutic results of embolectomy and thrombolysis for lower extremity deep vein thrombosis in 165 patients. Methods Embolectomy was undertaken with Fogarty catheter in 64 patients while 101 patients were treated by thrombolytic agents. Results Ninety-six cases (58.2%) were followed-up, ranging from 7 months to 218 months with an averge of 71 months including 44 cases undergoing embolectomy and 52 cases receiving thrombolytic agents. Symptoms disappeared in 20.5% of patients in embolectomy group and in 13.5% in thrombolytic group.In embolectomy group,the superficial varicoses and derma pigmentation in lower extremity appeared in 31.8% of patients,while in thrombolytic group the signs appeared in 50.5% of patients, respectively.Conclusions Embolectomy protecting the valve of deep trunk vein in some patients helps to reduce later complications of lower extremity deep venous thrombosis.
4.Intravenous injection of exogenous rIL-10 plasmid DNA and its expression in rats
Yuehong HUANG ; Yunxin CHEN ; Zhixin CHEN ; Xiaozhong WANG
Chinese Pharmacological Bulletin 1986;0(06):-
Aim To establish a method of hydrodynamic-based transfection(HBT) and provide a means in rats of the gene therapy of liver diseases,which allowed an efficient expression of rIL-10 gene in rat liver.Methods Using rIL-10 gene as a reporter gene,different volumes and doses of plasmid DNA solutions were rapidly injected into rat tail vein,then the serum and the tissue of liver,kidney,lung,spleen and heart in different time were collected and the expression of rIL-10 was detected by the methods of RT-PCR,ELISA and immunochemistry.Results Using rIL-10 gene as a reporter gene,the results demonstrated that an efficient transfer and expression of rIL-10 in rat liver could be achieved by a rapid injection of a large volume of rIL-10 DNA solution into rat via tail vein.Maintaining a stable expression of rIL-10 in serum could be assessed by repeated administration.Conclusion The HBT was a simple,convenient and efficient method of gene transfer and expression in rats,which could be used as an effective means to study further gene therapy of rIL-10 in liver diseases.
5.Mechanism of alternative splicing and its application in diagnosis and treatment of leukemia
Jing LIU ; Jing ZHANG ; Bo HUANG ; Xiaozhong WANG
Chinese Journal of Laboratory Medicine 2015;38(11):730-732
Alternative splicing is a process refering a pre-mRNA transforms to different mature mRNAs by different splicing sites combination, and then the mRNAs translate to various proteins.This process is regulated by a variety of cis acting elements and trans acting factors.Recent studies have shown that aberrant alternative splicing is prevalent in leukemia patients, and is closely associated with leukemic occurrence, development and chemotherapy resistance.This shows us that aberrant altemative splicing may be helpful to leukemia diagnosis and treatment.
6.Development of improved enzymatic creatinine reagents
Qingping HUANG ; Yanbo WO ; Guichun ZHANG ; Xiaozhong CAI
International Journal of Laboratory Medicine 2015;(4):503-505
Objective To develop improved enzymatic creatinine(Cr)assay reagents (self-R&D),and to investigate their appli-cation on serum detection by comparing with imported commercial Cr reagents(enzymatic Cr reagents from Toyobo)Methods En-zymatic method was used to evaluate the effect of every component and different concentrations of reagents on Cr assay by detecting the alteration of absorbance of Cr before or after the reaction.Meanwhile,the blank absorbance and analysis sensitivity of self-R&D and imported reagents,the technical indicators of precision,linearity,as well as method comparison of self-R&D reagents,were de-tected on the same automatic biochemical analyzer.Results The blank absorbance of self-R&D reagents was 0.009,and the detec-tion sensitivity was 0.13,better than that of imported Cr reagents.The coefficient of variation (CV)of high and low values of ser-um of self-R&D reagents were 1.5%,and 1.1%,respectively.The linear range was 0-2 850 μmol/L and the method comparison result was Y =0.98X +1.15 (r =0.999).The expected bias was less than the allowable error region.Using relative deviation≥10% as an index to evaluate the existence of significant interference,it shows that 35 mmol/L of creatine,3.42 mmol/L of biliru-bin,0.03 g/L of vitamin C,5 g/L of hemoglobin and 1450 FTU chyle in both low and high concentration serum samples did not interfere with the test result.Conclusion The quality of self-R&D reagents was good,and there was a good relativity between self-R&D reagents and imported Cr reagents with excellent quality.This indicates the self-R&D reagents could satisfy the application requirements of the clinics.
7.Antibacterial mechanism and safety of zinc oxide
Rong XIANG ; Dongbo DING ; Liangliang FAN ; Xiaozhong HUANG ; Kun XIA
Chinese Journal of Tissue Engineering Research 2014;(3):470-475
BACKGROUND:Zinc oxide has shown extraordinary antibacterial effect. But the antibacterial mechanisms of zinc oxide have not been wel developed, and the safety of zinc oxide has not yet been confirmed.
OBJECTIVE:To summarize the antibacterial mechanism and safety of zinc oxide based on the current research situation of zinc oxide.
METHODS:The CNKI database and PubMed database (2005-01/2013-08) were used to search the related articles about zinc oxide antibacterial mechanism and safety. The retrieval keywords were“zinc oxide or ZnO, antibacterial”,“zinc oxide or ZnO, safety”both in English and Chinese.
RESULTS AND CONCLUSTION:The antibacterial mechanism of zinc oxide is complex. Zinc oxide reveals its antibacterial power by photo catalysis, zinc ion dissolve out, and active oxygen. But the relationship between photo catalysis and active oxygen is different based on different studies. The safety of zinc oxide is not confirmed, and different studies have different results. Especial y for the nano-zinc oxide, some studies have showed that the zinc oxide is toxic. Al of these mean much more researches are needed to verify the safety of zinc oxide.
8.Catheter-directed thrombolysis for lower limb deep venous thrombosis
Xiaozhong HUANG ; Wei LIANG ; Meng YE ; Jiwei ZHANG
Journal of Interventional Radiology 1992;0(01):-
Objective To evaluate the efficacy of catheter-directed thrombolysis in the treatment of lower limb acute deep venous thrombosis(DVT). Methods One hundred and four patients with lower limb acute DVT underwent cathter-directed thrombolysis with continuous infusion of urokinase(154.27 ? 76.31 ? 104 IU). Fourteen pationts were implanted with stents for the residual stenoses. The circumferences between normal and affected limbs were measured before and after the thrombolysis. The venous patency score, the rate of patency improvement were eveluated by venography and the patients were followed up for six months. Results After thrombolysis, the venography revealed that venous patency improved in 92 patients(mean 52.42% ? 16.37%, P
9.Intraluminal venous catheter-directed thrombolysis for lower limb acute deep venous thrombosis
Xiaozhong HUANG ; Jiwei ZHANG ; Wei LIANG ; Jiachang CHI
Journal of Interventional Radiology 2006;0(10):-
Objective To evaluate the efficacy of intraluminal catheter-directed thrombolysis in treatment of lower limb acute deep venous thrombosis(DVT).Methods Thirty-six consecutive patients with lower limb acute DVT underwent intraluminal cathter-directed thrombolysis with urokinase continuous infusion immediately.The circumferences of the normal and affected limbs were measured before and after lysis,the venous patency scores and the rates of patency improvement were observed by venograms,together with follow up record after 6 months.Results After lysis,the circumferencial differences in thigh and calf showed significant difference(P
10.Effects of rat interleukin-10 gene treatment on expression of collagen, MMP13 and TIMP1 in fibrotic rats
Yuehong HUANG ; Yunxin CHEN ; Lijuan ZHANG ; Zhixin CHEN ; Xiaozhong WANG
Chinese Journal of Immunology 2014;(5):613-617
Objective:To study the effects of rat interleukin-10 (rIL-10) gene treatment on the expression of collagen , matrix metalloproteinase 13(MMP13) and their specific inhibitors the tissue inhibitor of metalloproteinase 1(TIMP1) in porcine serum in-duced liver fibrosis rats then to explore the anti-fibrotic effect of rL-10.Methods:Thirty SD rats were divided into normal control and fibrosis model group.Normal control group (group C) was intraperitoneally injected with 0.5 ml normal sodium twice a week for 8 week, while the fibrosis model group was injected with equal volume of pig serum for 8 week.At the beginning of the 5th week, fibrosis model group was further randomly divided into a fibrosis model subgroup ( group M ) , rIL-10 gene treatment subgroup ( group I ) and empty vector control subgroup(group P).Rats in group C and M were injected with Ringer’s solution as a reagent control via the tail vein weekly, rats in group I were injected with the rIL-10 plasmid pcDNA3-rIL-10, and rats in group P were injected with empty vector pcDNA3.All rats were sacrificed at the end of 8th week, and the liver tissue samples were collected to observe deposition of collegan in liver tissue by sirius red staining and detected the expression of MMP 13 and TIMP1 in the liver tissue by SP immunohistochemistry .Re-sults:Sirius red staining showed that the area of the collegan deposition was dramatically increased in fibrosis model subgroup and emp -ty vector control subgroup compared with the normal control group , and the area of the collagen deposition was dramatically decreased in rIL-10 gene treatment subgroup compared with the fibrosis model and empty vector control subgroup .Immunohistochemistry analysis showed that the expression of MMP 13 and TIMP1 in fibrosis model subgroup and empty vector control subgroup was significantly higher than the normal control group , but compared with normal control group , expression of MMP13 was significantly increased and expres-sion of TIMP1 was significantly decreased in rIL-10 gene treatment subgroup .Compared with fibrosis model subgroup and empty vector control subgroup, the expression of MMP13 and TIMP1 was dramatically decreased in rIL-10 gene treatment subgroup.Conclusion:rIL-10 gene treatment attenuates the area of collagen deposition in liver fibrosis rats associated with downregulation of TIMP 1.